Disclaimer

This site contains medical information that is intended for residents of the United States only and is not meant to be a substitute for the advice provided by a medical professional. Always consult a healthcare provider if you have health concerns. For residents outside of the US, please go to www.merckserono.net for information.

Other Websites

Please visit these sites for additional information on activities.

Merck Serono S.A. Website
EMD Serono, Inc. Websites
(These sites are intended for U.S. residents only.)
  • MSLifeLines.com
    MS LifeLinesSM is a free educational support service for people living with Multiple Sclerosis and their caregivers.
  • Rebif.com
    Rebif.com provides information on treatment with Rebif® (interferon beta-1a) and is for people who are newly diagnosed with relapsing forms of Multiple Sclerosis or those looking to change therapies.
  • Novantrone.com
    Novantrone.com offers information for patients and healthcare professionals about worsening MS as well as treatment with Novantrone® (mitoxantrone for injection concentrate).
  • FertilityLifeLines.com
    Fertility LifeLines™ is a free, confidential educational resource that provides customized information and support to people with fertility health concerns.
  • SaizenUS.com
    SaizenUS is a resources for information on growth hormone deficiency and treatment with Saizen® .
  • CoolLearnings.com
    Coollearnings.com teaches kids about growth hormone deficiency and treatment.
  • HIVwasting.com
    HIVwasting.com provides in-depth information on Serostim® , Seroject™ and SeroCare® as well as the Serono Secured Distribution Program.
  • Serostim.com
    This site provides information on Serostim® [somatropin (rDNA origin) for injection], the only growth hormone approved by the US Food and Drug Administration for the treatment of HIV-wasting or cachexia.
  • Zorbtive.com
    This site is all about Zorbtive™, the first significant treatment advance for Short Bowel Syndrome in nearly 35 years.
        © 2008 EMD Serono, Inc.

        Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.

        Last updated: 5/28/2008